Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.16 USD | -2.69% | -6.81% | -29.76% |
Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.76% | 905M | |
-19.45% | 130M | |
-18.31% | 59.78M | |
+2.98% | 58.78M | |
-2.40% | 50.16M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- Insider Trends: MiMedx Group Insider Sale Interrupting 90-Day Buy Trend